![]() |
市場調查報告書
商品編碼
2056524
生物安全檢測市場規模、佔有率、趨勢和預測:按產品/服務、檢測類型、應用和地區分類,2026-2034年Biological Safety Testing Market Size, Share, Trends, and Forecast by Product and Services, Test Type, Application, and Region, 2026-2034 |
||||||
2025年全球生物安全檢測市場規模為54.6億美元,預計2026年至2034年將以9.97%的複合年成長率成長,到2034年達到146.2億美元。生物製藥研發管線的快速擴張、細胞和基因治療產品需求的激增、監管力度的加強以及對疫情防範的日益重視,都是推動生物製藥安全檢測市場成長的主要因素。在產品領域,試劑盒和試劑將佔據主導地位,到2025年將達到41.3%的市場佔有率;在應用領域,疫苗研發將佔最大佔有率,達到28.7%。北美地區到2025年將佔區域需求的38.8%。
生物安全櫃(BSC)是一種通風的實驗室工作空間,旨在保護工作人員和設備免受各種病原體的污染。這些櫃子最大限度地減少了有害病毒、細菌和其他微生物的生物暴露。它們分為三類:I 類、II 類和 III 類。 I 類櫃保護操作人員及周圍環境。 II 類櫃保護操作人員、環境和樣品,適用於低至中度風險的生物製劑。 III 類櫃透過高度氣密的機殼提供最高等級的保護。這些櫃子可以根據需要進行客製化,以提供不同程度的保護,從而最佳化產品品質控制並最大限度地降低潛在的污染風險。
傳染病風險的增加和持續蔓延的病毒大流行是推動市場成長的主要因素。隨著新冠肺炎疫情在全球持續感染疾病,醫療機構對生物安全櫃(BSC)的需求顯著成長。此外,保護產品、人員和環境免受生物危害暴露和交叉污染的需求日益成長,也促進了市場成長。生物安全櫃廣泛應用於診斷檢查室和製藥公司,以維持藥品的微生物品質。此外,各種產品創新,例如改進結構、氣流模式、流速和排氣系統的新型生物安全櫃,也正在推動市場成長。這些生物安全櫃還配備了便於控制的數位介面和高效能空氣微粒過濾器(HEPA),以維持環境無菌。實驗室設備的快速現代化和醫療基礎設施的改善等其他因素預計也將進一步推動市場成長。
The global biological safety testing market size was valued at USD 5.46 Billion in 2025 and is projected to reach USD 14.62 Billion by 2034, at a CAGR of 9.97% during 2026-2034. Rapid expansion of biopharmaceutical pipelines, surging demand for cell and gene therapy products, increasing regulatory scrutiny, and heightened focus on pandemic preparedness are collectively propelling biological safety testing market growth. Kits and Reagents lead product segments with a 41.3% share in 2025, while Vaccine Development dominates application segments with 28.7%. North America commands regional demand at 38.8% share in 2025.
A biological safety cabinet (BSC) refers to a ventilated laboratory workspace designed for protecting workers and equipment from contamination through various pathogens. The cabinets minimize the biological exposure from harmful viruses, bacteria and other microorganisms. They are classified into three classes I, II and III. Class I cabinets protect the user and the surrounding environment. Class II cabinets protect the user, environment and the samples and are used for low to moderate risk biological agents and class III cabinets offer maximum protection through gas-tight enclosures. They can be customized to provide different protection levels to obtain optimum control over product quality and minimize the potential risks of contamination.
The increasing risks of communicable diseases, along with the on-going viral pandemic, is among the key factors driving the growth of the market. As the coronavirus disease (COVID-19) continues to spread across the globe, there has been a significant increase in the demand for BSCs in healthcare centers. Furthermore, the rising requirement to safeguard the product, personnel and environment from biohazard exposure and cross-contamination is providing a thrust to the market growth. BSCs are widely used by diagnostic labs and pharmaceutical manufacturers to maintain the microbiological quality of drugs. Additionally, various product innovations, such as the development of cabinet variants with improved construction, airflow pattern, velocities and exhaust systems, are acting as other growth-inducing factors. They are also equipped with digital interfaces for easy control of the cabinet and high-efficiency particulate air (HEPA) filters to maintain the sterility of the environment. Other factors, including the rapid modernization of laboratory equipment, along with improvements in the healthcare infrastructure, are anticipated to drive the market further.
The publisher provides an analysis of the key trends in each sub-segment of the global biological safety cabinet market report, along with forecasts at the global, regional and country levels from 2026-2034. Our report has categorized the market based on type and end user.
The report has also analysed the competitive landscape of the market with some of the key players being Air Science, Berner International, BIOBASE, Esco Micro Pte Ltd., EUROCLONE SPA (AddLife Development AB), Germfree Laboratories, Kewaunee Scientific Corporation, Labconco, NuAire (Polypipe), The Baker Company, Inc. and Thermo Fisher Scientific Inc.